Nitazoxanide - A review of its use in the treatment of gastrointestinal infections

被引:127
作者
Anderson, Vanessa R.
Curran, Monique P.
机构
[1] Wolters Kluwer Hlth, Adis, Auckland, New Zealand
[2] Wolters Kluwer Hlth, Conshohocken, PA USA
关键词
nitazoxanide; antiprotozoal; antihelminthic; tizoxanide; gastrointestinal infections; diarrhoea; pharmacodynamics; pharmacokinetics; therapeutic use tolerability;
D O I
10.2165/00003495-200767130-00015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitazoxanide (Alinia((R)), Daxon((R)), Dexidex((R)), Paramix((R)), Kidonax((R)), Colufase((R)), Annita((R))) has in vitro activity against a variety of microorganisms, including a broad range of protozoa and helminths. Nitazoxanide is effective in the treatment of protozoal and helminthic infections, including Cryptosporidium parvum or Giardia lamblia, in immunocompetent adults and children, and is generally well tolerated. Nitazoxanide is a first-line choice for the treatment of illness caused by C. parvum or G. lamblia infection in immunocompetent adults and children, and is an option to be considered in the treatment of illnesses caused by other protozoa and/or helminths.
引用
收藏
页码:1947 / 1967
页数:21
相关论文
共 89 条
[41]   Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni [J].
Hoffman, Paul S. ;
Sisson, Gary ;
Croxen, Matthew A. ;
Welch, Kevin ;
Harman, W. Dean ;
CremadeS, Nunilo ;
Morash, Michael G. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) :868-876
[42]  
Huang David B, 2004, Semin Pediatr Infect Dis, V15, P253, DOI 10.1053/j.spid.2004.07.006
[43]   An open-label clinical study of nitazoxanide in the treatment of human fascioliasis [J].
Kabil, SM ;
El Ashry, E ;
Ashraf, NK .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (06) :339-345
[44]   Rotavirus vaccine (RotaTeq®) [J].
Keating G.M. .
Pediatric Drugs, 2006, 8 (3) :197-202
[45]  
*KID, 2006, MEX PRESCR INF
[46]   Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model [J].
Li, X ;
Brasseur, P ;
Agnamey, P ;
Leméteil, D ;
Favennec, L ;
Ballet, JJ ;
Rossignol, JF .
FOLIA PARASITOLOGICA, 2003, 50 (01) :19-22
[47]   Transient neonatal Cryptosporidium parvum infection triggers long-term jejunal hypersensitivity to distension in immunocompetent rats [J].
Marion, Rachel ;
Baishanbo, Asiya ;
Gargala, Gilles ;
Francois, Arnaud ;
Ducrotte, Philippe ;
Duclos, Celia ;
Fioramonti, Jean ;
Ballet, Jean Jacques ;
Favennec, Loic .
INFECTION AND IMMUNITY, 2006, 74 (07) :4387-4389
[48]   In vitro and in vivo activities of nitazoxanide against Clostridium difficile [J].
McVay, CS ;
Rolfe, RD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2254-2258
[49]   Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole [J].
Mégraud, F ;
Occhialini, A ;
Rossignol, JF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :2836-2840
[50]  
MONTRESOR A, GUIDELINES EVALUATIO